Ask a research peptide supplier how to prepare a compound, or what it does, and a compliant one will decline. That reads as unhelpful, and customers occasionally say so. It is worth explaining the reasoning, because once you see it you can use it as a diagnostic on every supplier you deal with.
The question behind the question
Whether an article is a drug turns on intended use, and intended use is established from the seller’s representations. Instructions on how to prepare material for administration describe a person administering it. A statement about what a compound does describes an effect on a body. Each is evidence about intended use, and each is generated by the supplier, in writing, at the supplier’s own initiative.
So the refusal is not squeamishness. Answering would convert a laboratory reference material into something the seller has represented as being for use in humans, and no disclaimer elsewhere on the site undoes an answer given in an email.
What a supplier can properly answer
- Identity. What the compound is, its sequence, how the name maps to a structure.
- Vial contents. Nominal mass, net peptide content, counter-ion form, physical form.
- Published analysis. What was measured, by what method, by whom, and where to read it.
- Catalogue navigation. Which product a name refers to, how products differ, what is in stock.
- Order status. Dispatch, tracking, invoicing, purchase orders, eligibility.
That is a substantial list, and a supplier who handles it well is genuinely useful. It simply stops short of the line rather than at the point where a customer stops asking.
What a supplier cannot properly answer
- How to prepare or reconstitute material.
- How to store it after delivery.
- What quantity to use.
- What the compound does, in any organism.
- Whether it is suitable for a particular protocol or objective.
Every one of these is a determination for the qualified researcher and their institution, working from primary literature and their own procedures. A supplier is not the right source for any of them even setting the legal framework aside — we know what is in the vial, not what your experiment requires.
Using this as a supplier test
Ask a prospective supplier a preparation question deliberately. A supplier who answers has told you their research-use-only designation is decorative, that they are generating evidence of intended use in writing, and that their regulatory exposure is real. A supplier who declines and redirects you to identity, contents and published analysis has told you the opposite.
The helpful answer is the warning sign. That inversion is counter-intuitive enough that it is worth stating plainly, because most buyers instinctively reward the supplier who answers.
Our position
We answer questions about catalogue identity, vial contents, published test results and order status. We do not provide preparation, handling or dosing guidance of any kind, and we will not speculate about outcomes. That is a boundary we hold consistently, including when a customer would prefer we did not.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.